Dear all, please see below - surprisingly bioRxiv does not think our manuscript fits and they require more analysis/data. Shall we quickly submit to arXiv instead? Just let me know! Best, Robert -- Dr. Robert Prevedel Group Leader and Senior Scientist Cell Biology and Biophysics Unit European Molecular Biology Laboratory Meyerhofstr. 1 69117 Heidelberg, Germany Phone: +49 6221 387-8722 Email: robert.prevedel@embl.de http://www.prevedel.embl.de
Begin forwarded message:
From: bioRxiv@openrxiv.org Subject: BIORXIV/2025/674600 -- Please Resubmit Date: 9. September 2025 at 08:33:58 WEST To: prevedel@embl.de, prevedel@embl.de
MS ID#: BIORXIV/2025/674600 MS TITLE: A standardized file format and open-source analysis framework for Brillouin microscopy data
Dear Robert Prevedel;
Thank you for submitting your manuscript to bioRxiv. bioRxiv is intended for complete research papers with new data/analysis rather than announcements of tools/resources/reagents and your submission falls into this category. We are, therefore, returning the manuscript to give you the opportunity to add analyses/data to support the utility of your tool/resource. This data can be added as supplemental information.
If you decide to make these edits, please resupply your manuscript to the above manuscript ID BIORXIV/2025/674600. Please do not submit the manuscript as a new submission with a different manuscript ID number as this will delay screening. You will find this manuscript in the "Papers returned for your attention" section of your author area. Please contact us if you have any questions.
The bioRxiv team
Hi Robert, First of all, thanks a lot for submitting! That’s too bad they won’t accept, but I guess it’s part of the game ^^ Regarding my proposals, I’m currently referencing my repository, which is not ideal but is already a good way to advertise there is something out there. I think pushing the preprint to arXiv instead is a great alternative, and should be accepted. If for some reason they reject it, I remember using research square and HAL in the past, so these might be good options too :) Best, Pierre Pierre Bouvet, PhD Post-doctoral Fellow Medical University Vienna Department of Anatomy and Cell Biology Wahringer Straße 13, 1090 Wien, Austria
On 9/9/25, at 10:06, Robert Prevedel via Software <software@biobrillouin.org> wrote:
Dear all,
please see below - surprisingly bioRxiv does not think our manuscript fits and they require more analysis/data.
Shall we quickly submit to arXiv instead? Just let me know!
Best,
Robert -- Dr. Robert Prevedel Group Leader and Senior Scientist Cell Biology and Biophysics Unit European Molecular Biology Laboratory Meyerhofstr. 1 69117 Heidelberg, Germany
Phone: +49 6221 387-8722 Email: robert.prevedel@embl.de http://www.prevedel.embl.de
Begin forwarded message:
From: bioRxiv@openrxiv.org Subject: BIORXIV/2025/674600 -- Please Resubmit Date: 9. September 2025 at 08:33:58 WEST To: prevedel@embl.de, prevedel@embl.de
MS ID#: BIORXIV/2025/674600 MS TITLE: A standardized file format and open-source analysis framework for Brillouin microscopy data
Dear Robert Prevedel;
Thank you for submitting your manuscript to bioRxiv. bioRxiv is intended for complete research papers with new data/analysis rather than announcements of tools/resources/reagents and your submission falls into this category. We are, therefore, returning the manuscript to give you the opportunity to add analyses/data to support the utility of your tool/resource. This data can be added as supplemental information.
If you decide to make these edits, please resupply your manuscript to the above manuscript ID BIORXIV/2025/674600. Please do not submit the manuscript as a new submission with a different manuscript ID number as this will delay screening. You will find this manuscript in the "Papers returned for your attention" section of your author area. Please contact us if you have any questions.
The bioRxiv team
_______________________________________________ Software mailing list -- software@biobrillouin.org To unsubscribe send an email to software-leave@biobrillouin.org
Hi Robert, Slightly annoying but yes sounds good to resubmit to arxiv. Hopefully it goes through there without any issue! Best, Sal Sent from Outlook for Android<https://aka.ms/AAb9ysg> ________________________________ From: Robert Prevedel via Software <software@biobrillouin.org> Sent: Tuesday, September 9, 2025 10:06:27 AM To: Software Mailing list <software@biobrillouin.org> Subject: [Software] Fwd: BIORXIV/2025/674600 -- Please Resubmit Dear all, please see below - surprisingly bioRxiv does not think our manuscript fits and they require more analysis/data. Shall we quickly submit to arXiv instead? Just let me know! Best, Robert -- Dr. Robert Prevedel Group Leader and Senior Scientist Cell Biology and Biophysics Unit European Molecular Biology Laboratory Meyerhofstr. 1 69117 Heidelberg, Germany Phone: +49 6221 387-8722 Email: robert.prevedel@embl.de http://www.prevedel.embl.de Begin forwarded message: From: bioRxiv@openrxiv.org Subject: BIORXIV/2025/674600 -- Please Resubmit Date: 9. September 2025 at 08:33:58 WEST To: prevedel@embl.de, prevedel@embl.de MS ID#: BIORXIV/2025/674600 MS TITLE: A standardized file format and open-source analysis framework for Brillouin microscopy data Dear Robert Prevedel; Thank you for submitting your manuscript to bioRxiv. bioRxiv is intended for complete research papers with new data/analysis rather than announcements of tools/resources/reagents and your submission falls into this category. We are, therefore, returning the manuscript to give you the opportunity to add analyses/data to support the utility of your tool/resource. This data can be added as supplemental information. If you decide to make these edits, please resupply your manuscript to the above manuscript ID BIORXIV/2025/674600. Please do not submit the manuscript as a new submission with a different manuscript ID number as this will delay screening. You will find this manuscript in the "Papers returned for your attention" section of your author area. Please contact us if you have any questions. The bioRxiv team This message and any attachment are intended solely for the addressee and may contain confidential information. If you have received this message in error, please contact the sender and delete the email and attachment. Any views or opinions expressed by the author of this email do not necessarily reflect the views of the University of Nottingham. Email communications with the University of Nottingham may be monitored where permitted by law.
Yes, I agree – let’s do arXiv then. From: Robert Prevedel via Software <software@biobrillouin.org> Reply to: Robert Prevedel <prevedel@embl.de> Date: Tuesday, 9. September 2025 at 10:06 To: Software Mailing list <software@biobrillouin.org> Subject: [EXTERN] [Software] Fwd: BIORXIV/2025/674600 -- Please Resubmit Dear all, please see below - surprisingly bioRxiv does not think our manuscript fits and they require more analysis/data. Shall we quickly submit to arXiv instead? Just let me know! Best, Robert -- Dr. Robert Prevedel Group Leader and Senior Scientist Cell Biology and Biophysics Unit European Molecular Biology Laboratory Meyerhofstr. 1 69117 Heidelberg, Germany Phone: +49 6221 387-8722 Email: robert.prevedel@embl.de http://www.prevedel.embl.de Begin forwarded message: From: bioRxiv@openrxiv.org Subject: BIORXIV/2025/674600 -- Please Resubmit Date: 9. September 2025 at 08:33:58 WEST To: prevedel@embl.de, prevedel@embl.de MS ID#: BIORXIV/2025/674600 MS TITLE: A standardized file format and open-source analysis framework for Brillouin microscopy data Dear Robert Prevedel; Thank you for submitting your manuscript to bioRxiv. bioRxiv is intended for complete research papers with new data/analysis rather than announcements of tools/resources/reagents and your submission falls into this category. We are, therefore, returning the manuscript to give you the opportunity to add analyses/data to support the utility of your tool/resource. This data can be added as supplemental information. If you decide to make these edits, please resupply your manuscript to the above manuscript ID BIORXIV/2025/674600. Please do not submit the manuscript as a new submission with a different manuscript ID number as this will delay screening. You will find this manuscript in the "Papers returned for your attention" section of your author area. Please contact us if you have any questions. The bioRxiv team _______________________________________________ Software mailing list -- software@biobrillouin.org To unsubscribe send an email to software-leave@biobrillouin.org
participants (4)
-
Kareem Elsayad -
Pierre Bouvet -
Robert Prevedel -
Sal La Cavera III (staff)